FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial
在转移性结直肠癌患者的二线治疗中,与单药伊立替康相比,FOLFIRI方案(亚叶酸钙、氟尿嘧啶和伊立替康)并未提高疗效,反而增加了毒性:一项随机临床试验
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359211068737
Zhang, Xiaowei; Duan, Ran; Wang, Yusheng; Liu, Xin; Zhang, Wen; Zhu, Xiaodong; Chen, Zhiyu; Shen, Wei; He, Yifu; Wang, Hong Qiang; Huang, Mingzhu; Wang, Chenchen; Zhang, Zhe; Zhao, Xiaoying; Qiu, Lixin; Luo, Jianfeng; Sheng, Xuedan; Guo, Weijian